Myozyme 50 mg powder for concentrate for solution for infusion, Opfolda 65 mg hard capsules, Pombiliti 105 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion
Approved small_molecule active
Quick answer
Myozyme 50 mg powder for concentrate for solution for infusion, Opfolda 65 mg hard capsules, Pombiliti 105 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion for Pompe disease is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Pompe disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- active